NDTV Profit’s special research section collates quality and in-depth equity and economy research reports from across India’s top brokerages, asset managers and research agencies. These reports offer NDTV Profit’s subscribers an opportunity to expand their understanding of companies, sectors and the economy.
Systematix Research Report
The seven EMS companies under our coverage reported 27%/20%/17% YoY rise in revenue/Ebitda/profit after tax and were broadly inline with our estimates. Kaynes and PG Electroplast results beat our estimates (also gave strong guidance); Avalon and Dixon Technologies missed estimates by a wide margin.
Elin continued to report weak results while Amber Enterprises’ healthy margins made up for its weak revenue. Syrma's profit after tax declined 17% YoY despite a 67% YoY surge in revenue.
Despite a mixed bag Q4, companies remained bullish on their growth outlook (refer company section). Government of India’s vision of Make in India, Make for world, backed by various schemes and incentives have aided to India’s growing acceptance as an alternate manufacturer to China.
Import substitution and India’s rising penetration in the domestic market provide a large opportunity for the Indian EMS industry. We thus remain structurally positive on the industry.
Click on the attachment to read the full report:
Also Read: Ixigo IPO - Investment Rationale, Issue Details, Key Strategies, Risks And More: Anand Rathi
DISCLAIMER
This report is authored by an external party. NDTV Profit does not vouch for the accuracy of its contents nor is responsible for them in any way. The contents of this section do not constitute investment advice. For that you must always consult an expert based on your individual needs. The views expressed in the report are that of the author entity and do not represent the views of NDTV Profit.
Users have no license to copy, modify, or distribute the content without permission of the Original Owner.
RECOMMENDED FOR YOU

'Buy' Inox Wind Shares For Potential Upside Of 35% Says Axis Securities


Fine Organic, PCBL, Vinati Organics Are PL Capital's Top Picks In Chemical Sector — Check Target Price


Lupin Q1 Review: Dolat Capital Maintains 'Add', But Cuts Target Price — Here's Why


'Hold' UPL Shares Maintains Nirmal Bang Post Q1 Results — Check Target Price
